Epidemiology of Pulmonary and Extrapulmonary Nontuberculous Mycobacteria Infections at 4 US Emerging Infections Program Sites: A 6-Month Pilot
Clinical Infectious Diseases · 2023
DOI: 10.1093/cid/ciad214 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Infectious Diseases, 2023. Verfasst von Cheri Grigg und 17 weiteren Autor:innen. Beteiligte Einrichtung: Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia, USA. Hauptthemen laut MEDLINE: Mycobacterium Infections, Nontuberculous, Lung Diseases. Die Arbeit wurde bisher 56-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: CDC, Emerging Infections Program (EIP; cooperative agreement, Division of Intramural Research, National Institute for Allergy and Infectious Diseases.
Abstract (Originalsprache)
Background
Nontuberculous mycobacteria (NTM) cause pulmonary (PNTM) and extrapulmonary (ENTM) disease. Infections are difficult to diagnose and treat, and exposures occur in healthcare and community settings. In the United States, NTM epidemiology has been described largely through analyses of microbiology data from health departments, electronic health records, and administrative data. We describe findings from a multisite pilot of active, laboratory- and population-based NTM surveillance.
Methods
The Centers for Disease Control and Prevention’s Emerging Infections Program conducted NTM surveillance at 4 sites (Colorado, 5 counties; Minnesota, 2 counties; New York, 2 counties; and Oregon, 3 counties [PNTM] and statewide [ENTM]) from 1 October 2019 through 31 March 2020. PNTM cases were defined using published microbiologic criteria. ENTM cases required NTM isolation from a nonpulmonary specimen, excluding stool and rectal swabs. Patient data were collected via medical record review.
Results
Overall, 299 NTM cases were reported (PNTM: 231, 77%); Mycobacterium avium complex was the most common species group. Annualized prevalence was 7.5/100 000 population (PNTM: 6.1/100 000; ENTM: 1.4/100 000). Most patients had signs or symptoms in the 14 days before positive specimen collection (ENTM: 62, 91.2%; PNTM: 201, 87.0%). Of PNTM cases, 145 (62.8%) were female and 168 (72.7%) had underlying chronic lung disease. Among ENTM cases, 29 (42.6%) were female, 21 (30.9%) did not have documented underlying conditions, and 26 (38.2%) had infection at the site of a medical device or procedure.
Conclusions
Active, population-based NTM surveillance will provide data for monitoring the burden of disease and characterize affected populations to inform interventions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
- Division of Disease Control and Public Health Response, Colorado Department of Public Health and Environment, Denver, Colorado, USA.
- Minnesota Department of Health, St. Paul, Minnesota, USA.
- New York State Department of Health, Albany, New York, USA.
- University of Rochester Medical Center, Rochester, New York, USA.
- Public Health Division, Oregon Health Authority, Portland, Oregon, USA.
ORCID-Profile: Cheri Grigg, Ghinwa Dumyati
Förderung
- CDC
- Emerging Infections Program (EIP; cooperative agreement
- Division of Intramural Research, National Institute for Allergy and Infectious Diseases
- NIH
- CDC EIP cooperative agreement
Zitieren
APA
Grigg, C., Jackson, K. A., Barter, D., Czaja, C. A., Johnston, H., Lynfield, R., Vagnone, P. S., Tourdot, L., Spina, N., Dumyati, G., Cassidy, P. M., Pierce, R., Henkle, E., Prevots, D. R., Salfinger, M., Winthrop, K. L., Toney, N. C., & Magill, S. S. (2023). Epidemiology of Pulmonary and Extrapulmonary Nontuberculous Mycobacteria Infections at 4 US Emerging Infections Program Sites: A 6-Month Pilot. Clinical Infectious Diseases. https://doi.org/10.1093/cid/ciad214
Vancouver
Grigg C, Jackson KA, Barter D, Czaja CA, Johnston H, Lynfield R, et al. Epidemiology of Pulmonary and Extrapulmonary Nontuberculous Mycobacteria Infections at 4 US Emerging Infections Program Sites: A 6-Month Pilot. Clinical Infectious Diseases. 2023. doi:10.1093/cid/ciad214
BibTeX
@article{Grigg2023,
author = {Grigg, Cheri and Jackson, Kelly A and Barter, Devra and Czaja, Christopher A and Johnston, Helen and Lynfield, Ruth and Vagnone, Paula Snippes and Tourdot, Laura and Spina, Nancy and Dumyati, Ghinwa and Cassidy, P Maureen and Pierce, Rebecca and Henkle, Emily and Prevots, D Rebecca and Salfinger, Max and Winthrop, Kevin L and Toney, Nadege Charles and Magill, Shelley S},
title = {Epidemiology of Pulmonary and Extrapulmonary Nontuberculous Mycobacteria Infections at 4 US Emerging Infections Program Sites: A 6-Month Pilot},
journal = {Clinical Infectious Diseases},
year = {2023},
doi = {10.1093/cid/ciad214}
}
EUVIMED